Glycemia management in acute ischemic stroke: current concepts and novel therapeutic targets

References

• Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67–71.
   PubMed Web of Science ®Google Scholar
• Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993 Jan;24(1):111–116.
   PubMed Web of Science ®Google Scholar
• Anderson RE, Tan WK, Martin HS, et al. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160–170.
   PubMed Web of Science ®Google Scholar
• Martini SR, Kent TA. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab. 2007 Mar;27(3):435–451.
   PubMed Web of Science ®Google Scholar
• Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Revue Neurol. 2010;6:145–155.
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Caso V, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis. 2009;28:119–123.
   PubMed Web of Science ®Google Scholar
• Baird TA, Parsons MW, Phan T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208–2214.
   PubMed Web of Science ®Google Scholar
• Lin SF, Chao AC, Hu HH, et al. Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a chinese population: A prospective cohort study. J Neurol Sci. 2018;388:195–202.
   PubMed Web of Science ®Google Scholar
• Poppe AY, Majumdar SR, Jeerakathil T, et al. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617–622.
   PubMed Web of Science ®Google Scholar
• Goyal N, Tsivgoulis G, Pandhi A, et al. Admission hyperglycemia and outcomes in large vessel occlusion strokes treated with mechanical thrombectomy. J Neurointerv Surg. 2018;10:112–117.
   PubMed Web of Science ®Google Scholar
• Lu GD, Ren ZQ, Zhang JX, et al. Effects of diabetes mellitus and admission glucose in patients receiving mechanical thrombectomy: A systematic review and meta-analysis. Neurocrit Care. 2018.
   Web of Science ®Google Scholar
• Kim JT, Jahan R, Saver JL, et al. Impact of glucose on outcomes in patients treated with mechanical thrombectomy: A post hoc analysis of the solitaire flow restoration with the intention for thrombectomy study. Stroke. 2016;47:120–127.
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Egli M, Faouzi M, et al. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke. 2010;41:2366–2370.
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–3013.
   PubMed Web of Science ®Google Scholar
• Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Jama. 2006;295:1681–1687.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim C, Jung KH, et al. Range of glucose as a glycemic variability and 3 month outcome in diabetic patients with acute ischemic stroke. PLoS One. 2017;12:e0183894.
   PubMed Web of Science ®Google Scholar
• JPT Higgins SGE. The cochrane handbook for systematic reviews of interventions. Oxford: The Cochrane Collaboration; 2011. Version 5.1.0.
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94.
   PubMed Web of Science ®Google Scholar
• Scott JF, Robinson GM, French JM, et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the glucose insulin in stroke trial (GIST). Stroke. 1999 Apr;30(4):793–799.
   PubMed Web of Science ®Google Scholar
• Vinichuk S, Melnyk V, Margitich V. Hyperglycemia after acute ischemic stroke: prediction, significance and immediate control with insulin-potassium-saline-magnesium infusions. Heart Drug. 2005 Oct;5(4):197–204.
   Google Scholar
• Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis. 2006;22(2–3):116–122.
   PubMed Web of Science ®Google Scholar
• Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008 Feb;39(2):384–389.
   PubMed Web of Science ®Google Scholar
• Azevedo JRA, Azevedo RP, Miranda MA, et al. Management of hyperglycemia in patients with acute ischemic stroke: comparison of two strategies. Crit Care. 2009;13(Suppl 3):P48.
   Google Scholar
• Vriesendorp TM, Roos YB, Kruyt ND, et al. Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):1040–1043.
   PubMed Web of Science ®Google Scholar
• Staszewski J, Brodacki B, Kotowicz J. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):150–154.
   PubMed Web of Science ®Google Scholar
• Fuentes B, Ntaios G, Putaala J, et al. European stroke organisation (ESO) guidelines on glycaemia management in acute stroke. Eur Stroke J. 2018;3:5–21.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;2018(49):e46–e110.
   Google Scholar
• Gentile N, Seftchick M, Huynh T, et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006 Feb;13(2):174–180.
   PubMed Web of Science ®Google Scholar
• Ribo M, Molina C, Delgado P, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. J Cereb Blood Flow Metab. 2007 Sep;27(9):1616–1622.
   PubMed Web of Science ®Google Scholar
• Rosso C, Corvol JC, Pires C, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke. Results from the randomized INSULINFARCT trial. Stroke. 2012 Sep;43(9):2343–2349.
   PubMed Web of Science ®Google Scholar
• Thomassen L, Brainin M, Demarin V, et al. Acute stroke treatment in Europe: a questionnaire-based survey on behalf of the EFNS task force on acute neurological stroke care. Eur J Neurol. 2003 May;10(3):199–204.
   PubMed Web of Science ®Google Scholar
• Fuentes B, Castillo J, San Jose B, et al. The prognostic value of capillary glucose levels in acute stroke: the glycemia in acute stroke (GLIAS) study. Stroke. 2009 Feb;40(2):562–568.
   PubMed Web of Science ®Google Scholar
• Allport L, Baird T, Butcher K, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006 Aug;29(8):1839–1844.
   PubMed Web of Science ®Google Scholar
• Kim N, Jhang Y, Park JM, et al. Aggressive glucose control for acute ischemic stroke patients by insulin infusion. J Clin Neurol. 2009 Dec;5(4):167–172.
   PubMed Web of Science ®Google Scholar
• Kruyt ND, Biessels GJ, Vriesendorp TM, et al. Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol EstablishesTight glycemic control. Neurocrit Care. 2010 Feb;12(1):62–68.
   PubMed Web of Science ®Google Scholar
• Johnston KC, Hall CE, Kissela BM, et al. Glucose regulation in acute stroke patients (GRASP) trial: a randomized pilot trial. Stroke. 2009 Dec;40(12):3804–3809.
   PubMed Web of Science ®Google Scholar
• Laird EA, Coates V. Systematic review of randomized controlled trials to regulate glycaemia after stroke. J Adv Nurs. 2013 Feb;69(2):263–277.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Papavasileiou V, Bargiota A, et al. Intravenous insulin treatment in acute stroke: a systematic review and meta-analysis of randomized controlled trials. Int J Stroke. 2014 Jun;9(4):489–493.
   PubMed Web of Science ®Google Scholar
• Bellolio M, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jan;23(1):CD005346.
   Google Scholar
• Johnston K, On behalf of SHINE investigators. Stroke hyperglycemia insulin network effort (SHINE) trial primary results. 2019 Feb. Oral presentation at the International Stroke Conference 2019, Honolulu, Hawaii: USA.
   Google Scholar
• Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007 May;6(5):397–406.
   PubMed Web of Science ®Google Scholar
• Fuentes B, Ortega-Casarrubios MA, Sanjose B, et al. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it? implications for outcome. Stroke. 2010 Oct;41(10):2362–2365.
   PubMed Web of Science ®Google Scholar
• Dziedzic T, Pera J, Trabka-Janik E, et al. The impact of postadmission glycemia on stroke outcome: glucose normalisation is associated with better survival. Atherosclerosis. 2010 Aug;211(2):584–588.
   PubMed Web of Science ®Google Scholar
• Bruno A, Liebeskind D, Hao Q, et al. Diabetes mellitus, acute hyperglycemia, and ischemic stroke. Curr Treat Options Neurol. 2010 Nov;12(6):492–503.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Egli M, Arsovska A, et al. An intravenous insulin protocol for strict glycemic control in acute ischaemic stroke. Eur J Neurol. 2012 Mar;19(3):443–451.
   PubMed Web of Science ®Google Scholar
• Darsalia V, Nathanson D, Nyström T, et al. GLP-1R activation for the treatment of stroke: updating and future perspectives. Rev Endocr Metab Disord. 2014 Sep;15(3):233–242.
   PubMed Web of Science ®Google Scholar
• Daly SC, Chemmanam T, Loh P-SP-S, et al. Exenatide in acute ischemic stroke. Int J Stroke. 2013 Oct;8(7):E44.
   PubMed Web of Science ®Google Scholar
• McGrath RT, Hocking SL, Priglinger M, et al. Rationale and design of short-term EXenatide therapy in acute ischaemic stroke (STEXAS): a randomised, open-label, parallel-group study. BMJ Open. 2016 Feb 24;6(2):e008203.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): national library of medicine (US). 2000 Feb 29 – identifier NCT03287076, trial of EXenatide in acute ischaemic stroke (TEXAIS). cited 2017 September 19. Available from: https://clinicaltrials.gov/ct2/show/NCT03287076.
   Google Scholar
• Clinical Trials Register. eu [Internet]. Amsterdam (NL): European medicines agency (EU). 1995 – identifier 2011–002780–16, prehospital lowering of glucose in stroke (PROLOGUES). cited 2012 April 03. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002780-16/SE.
   Google Scholar
• Mitchell EA, Coates VE, Ryan AA, et al. Hyperglycaemia monitoring and management in stroke care: policy vs. practice. Diabet Med. 2012 Sep;29(9):1108–1114.
   PubMed Web of Science ®Google Scholar
• Fuentes B, Sanz-Cuesta BE, Gutierrez-Fernandez M, et al. Glycemia in acute stroke II study: a call to improve post-stroke hyperglycemia management in clinical practice. Eur J Neurol. 2017 Sep;24(9):1091–1098.
   PubMed Web of Science ®Google Scholar
• Causabon LK, Saltman A, Peeva V, et al. Variability in physician care practices for glucose treatment in stroke patients. Can J Neurol Sci. 2008 Nov;35(5):573–582.
   PubMed Web of Science ®Google Scholar
• Alexandrov AW, Palazzo P, Biby S, et al. Back to basics: adherence with guidelines for glucose and temperature control in an American comprehensive stroke center sample. J Neurosci Nurs. 2018 Jun;50(3):131–137.
   PubMed Web of Science ®Google Scholar
• Laird EA, Coates VE, Ryann AA, et al. Hypoglycaemia risk among a hospitalised stroke patient cohort: a case for increased vigilance in glucose monitoring. J Clin Neurosci. 2014 Feb;21(2):232–235.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Davalos A, Eriksson N, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the safe implementation of treatments in stroke international stroke thrombolysis register (SITS-ISTR). Arch Neurol. 2010 Sep;67(9):1123–1130.
   PubMedGoogle Scholar
• Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36:1705–1709.
   PubMed Web of Science ®Google Scholar
• Desilles JP, Meseguer E, Labreuche J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis A registry and systematic review. Stroke. 2013 Jul;44(7):1915–1923.
   PubMed Web of Science ®Google Scholar
• Lou M, Safdar A, Mehdiratta M, et al. The HAT score. A simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008 Oct 28;71(18):1417–1423.
   PubMed Web of Science ®Google Scholar
• Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012 May;71(5):634–641.
   PubMed Web of Science ®Google Scholar
• Strbian D, Meretoja A, Ahlhelm FJ, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012 Feb 7;78(6):427–432.
   PubMed Web of Science ®Google Scholar
• McCormick M, Hadley D, McLean JR. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol. 2010 May;67(5):570–578.
   PubMed Web of Science ®Google Scholar
• Gordon WR, Salamo RM, Behera A, et al. Association of blood glucose and clinical outcome after mechanical thrombectomy for acute ischemic stroke. Interv Neurol. 2018 Apr;7(3–4):182–188.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou Z, Tian X, et al. Impact of relative blood glucose changes on mortality risk of patient with acute ischemic stroke and treated with mechanical thrombectomy. J Stroke Cerebrovasc Dis. 2019 Jan;28(1):213–219.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Z, Miao J, et al. High stress hyperglycemia ratio predicts poor outcome after mechanical thrombectomy for ischemic stroke. J Stroke Cerebrovasc Dis. 2019 Mar;16:S1052–3057(19)30066–7. [Epub ahead of print].
   Google Scholar
• Kim JT, Liebeskind DS, Jahan R, et al. Impact of hyperglycemia according to the collateral status on outcomes in mechanical thrombectomy. Stroke. 2018 Nov;49(11):2706–2714.
   PubMed Web of Science ®Google Scholar
• Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–842.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moreno EI, Camara Lemarroy CR, Gonzalez-Gonzalez JG, et al. Glycemic variability and acute ischemic stroke: the missing link? Transl Stroke Res. 2014 Dec;5(6):638–646.
   PubMed Web of Science ®Google Scholar
• Camara-Lemarroy C. Glucose and stroke: what about glycemic variability? J Neurol Sci. 2017 Feb;15(373):242–243.
   Web of Science ®Google Scholar
• Lim J, Kim C, Oh MS, et al. Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments. J Diabetes Complications. 2018 Jul;32(7):682–687.
   PubMed Web of Science ®Google Scholar
• Yoon JE, Sunwoo JS, Kim JS, et al. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients. J Diabetes Complications. 2017 Feb;31(2):390–394.
   PubMed Web of Science ®Google Scholar
• Hui J, Zhang J, Mao X, et al. The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke. Neurol Sci. 2018 Sep;39(9):1571–1577.
   PubMed Web of Science ®Google Scholar
• Kim JT, Lee SY, Yoo DS, et al. Clinical implications of serial glucose measurements in acute ischemic stroke patients treated with intravenous thrombolysis. Sci Rep. 2018 Aug 6;8(1):11761.
   PubMed Web of Science ®Google Scholar
• Mastrototaro J. The MiniMed continuous glucose monitoring system. J Pediatr Endocrinol Metab. 1999;12(Suppl 3):751–758.
   PubMed Web of Science ®Google Scholar
• Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004 6;Jun(3):339–347.
   Google Scholar
• Picconi F, Flavianni A, Malandrucco I, et al. The need for identifying standardized indices for measuring glucose variability. J Diabetes Sci Technol. 2012 Jan;6(1):218–219.
   PubMedGoogle Scholar
• Shimoyama T, Kimura K, Uemura J, et al. Post stroke dysglycemia and acute infarct volume growth: A study using continuous glucose monitoring. Eur Neurol. 2016;76(3–4):167–174.
   PubMed Web of Science ®Google Scholar
• Wada S, Yoshimura S, Inoue M, et al. Outcome prediction in acute stroke patients by continuous glucose monitoring. J Am Heart Assoc. 2018 Apr 12;7(8):e008744.
   Web of Science ®Google Scholar
• American Diabetes Association. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S173–S181.
   PubMed Web of Science ®Google Scholar